In the BioHarmony Drug Report Database
Diprivan (propofol) is a small molecule pharmaceutical. Propofol was first approved as Diprivan on 1989-10-02. It is used to treat delirium, pain, psychomotor agitation, and status epilepticus in the USA. It is known to target potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 and ferritin light chain. Propofol’s patent is valid until 2024-12-01 (FDA).
Image (chem structure or protein)